Navigation Links
Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
Date:6/25/2008

SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced that the company has successfully completed first-year milestones under a three-year, $6.0 million grant awarded in 2007, and is advancing with the development of a DNA vaccine manufacturing process with the potential to produce several million doses of vaccines in a matter of days.

The RapidResponse(TM) system is designed to allow extremely rapid and large-scale production of DNA vaccines with low capital requirements. It is ideally suited to enable an immediate response against emerging diseases affecting large populations, such as pandemic influenza or severe acute respiratory syndrome (SARS). The company is proceeding with the development of the RapidResponse(TM) platform under the second year of grant funding awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Separately, Vical has completed enrollment in its Phase 1 testing of the company's Vaxfectin(R)-formulated pandemic influenza DNA vaccines, and expects to release results by August 2008.

About the RapidResponse(TM) Platform

The RapidResponse(TM) DNA vaccine manufacturing platform is intended to significantly reduce the time required to develop, manufacture and deploy vaccines against emerging diseases during the early stages of an infectious outbreak. By using a cell-free manufacturing process, the company believes that the RapidResponse(TM) DNA platform can overcome the time, capacity and cost challenges of manufacturing conventional vaccines for diseases such as influenza, which use viruses grown in chicken eggs or via cell culture, requiring months of production time in large, dedicated
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
8. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like ... recent company developments. As Medifirst continues to expand its ... shareholders. Integrating social media into its investor relations strategy, ... post updates on Twitter.  The Facebook homepage is Medifirst ... Says CEO Bruce J. Schoengood ...
(Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2
(Date:5/22/2013)... (PRWEB) May 22, 2013 College ... have access to Adapt Courseware’s new Introduction ... an adaptive framework that responds based on each ... , the provider of comprehensive adaptive online curriculum ... continuing to develop introductory level general education offerings, ...
(Date:5/22/2013)... May 22, 2013 Beginning Aug. 22, ... the Conrad Foundation’s Spirit of Innovation Challenge . ... plan competition, free and open to students ages 13 ... Spirit of Innovation Challenge celebrates the life and entrepreneurial ... on the Moon. The program challenges teens to work ...
(Date:5/22/2013)... health officials from New Zealand, South Africa, Australia, Fiji ... countries to integrate rheumatic fever (RF) and rheumatic heart ... , "RHD was nearly eradicated in wealthy populations at ... a disease of poverty that kills children, adolescents and ... K. Srinath Reddy, President of the World Heart Federation. ...
(Date:5/22/2013)... TUESDAY, May 21 (HealthDay News) -- The overall health ... 10 people either overweight or obese and large numbers ... not exercising, a new government report shows. , , ... and Prevention, the report found Americans continuing to make ... soaring rates of heart disease, diabetes and other chronic ...
(Date:5/22/2013)... of Melbourne said this small increase in cancer risk ... scans in diagnosing and monitoring disease. , The study ... today and involved researchers at eight other centres ... Research on Cancer in Lyon, France. , Professor ... detailed three dimensional pictures to diagnose or exclude disease ...
Breaking Medicine News(10 mins):Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:Governments hold long-overdue meeting on reducing early death from rheumatic heart disease 2Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2
... (Nasdaq: ISIS ) announced that the Company will ... San Francisco, CA. Stanley T. Crooke, M.D., Ph.D., Chairman ... Company and an update on recent clinical and business activities.The ... on Monday, January 12, 2009. To access the live ...
... the leading,publisher of medical and scientific literature, announced ... American College of Cardiology,(ACC) ( http://www.acc.org ), the ... research. The agreement calls for Elsevier to publish,the ... of Cardiology,(JACC) ( http://www.elsevier.com/locate/jac ), for the ...
... hearty compared to other industries that have experienced massive layoffs lately. ... jobs in a single week, bringing the site,s job count to ... nursing profession, NursingCrossing aims to update its website with each and ... ...
... Jan. 8 Press Ganey Associates, Inc.,today announced ... of patient flow management tools and services for ... by,offering strategic solutions for patient flow issues such ... delayed surgeries, and lack of,available ICU and hospital ...
... Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... marketer of customized nutritional supplements, today announced that ... Weaver,s employment with NAI ended.NAI also announced it ... Wells Fargo Bank. Among other changes the ...
... at Protecting Medicare Beneficiaries Introduced on the First ... Physical therapy services for ... arbitrary financial caps under legislation introduced Tuesday in ... the American Physical Therapy Association (APTA). The Medicare ...
Cached Medicine News:Health News:Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 3Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 2Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 3Health News:Press Ganey Acquires PatientFlow Technology 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3
... the hand, the Jarvik 2000 pump is about ... welded titanium shell sits a direct-current motor, a ... single moving part: a small, spinning titanium impeller ... to 7 liters per minute. Rather than take ...
... cardiac assist system primarily designed as a permanent ... failure., ,It is a blood pump that connects ... to help the ailing hearts pumping function and ... , ,It can also be used as a ...
... The Masimo SET LNOP Blue Sensor is ... babies. The LNOP Blue sensor is ... accuracy claims for cyanotic infants and children. ... presented challenging conditions for reliable and accurate ...
... The Trinity Biotech Captia™ Varicella-Zoster Virus (VZV) ... for the detection and quantitative determination of ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
Medicine Products: